SCHEMBL627565

SCHEMBL627565

Cc1c(C)c2c(c(C)c1OC(C)CS(=O)(=O)O)CCC(C)(CCCC(C)CCCC(C)C)O2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
PDE4A P27815 1/20 0.68
PDE3A Q14432 1/20 0.68
GSTO1 P78417 2/20 0.67
PSEN1 P49768 3/20 0.66
LMNA P02545 3/20 0.64
TTPA P49638 3/20 0.64
MAPT P10636 2/20 0.64
GSTP1 P09211 1/20 0.64
USP2 O75604 1/20 0.64
THRB P10828 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
PTPN1 P18031 1/20 0.63
NR1I2 O75469 3/20 0.55
ALOX5 P09917 1/20 0.54
PGR P06401 1/20 0.48
AKT1 P31749 2/20 0.46
PDPK1 O15530 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627630 0.90 MEN1 (0.65) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL627860 0.89 MEN1 (0.64) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL628409 0.88 MEN1 (0.63) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL28432517 0.86 MEN1 (0.73) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL15960060 0.86 MEN1 (0.73) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL19096563 0.86 MEN1 (0.73) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL19096565 0.86 MEN1 (0.73) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL19321939 0.86 MEN1 (0.70) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL2784906 0.85 GSTO1 (0.76) MEN1KMT2APDE4APDE3AGSTO1
SCHEMBL628603 0.85 PSEN1 (0.72) MEN1KMT2APDE4APDE3AGSTO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461362-B2 Protein phosphatase 2A-activating agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-06-11 US disclosed
EP-2419414-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS The Ohio State University Research Foundation (US) 2012-02-22 EP disclosed
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO SATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 US disclosed
WO-2010120711-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS PPP2CA, PPP2R2A, PPP2R1A MEN1 4219/4885KMT2A 1918/4885PDE4A 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.